ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
Home
Press release
Jan 19, 2023 09:07 JST
Source:
Eisai
Eisai Listed as a Global 100 Most Sustainable Corporation for The Seventh Time Highest Ranked Global Pharmaceutical Company
TOKYO, Jan 19, 2023 - (JCN Newswire) - Eisai Co., Ltd. announced that it has been listed in the 2023 Global 100 Most Sustainable Corporations in the World (Global 100), a global ranking by Canada-based media and investment advisory company, Corporate Knights, Inc. This marks Eisai's seventh inclusion on the list. Ranked 53rd, Eisai was the highest ranking company among global pharmaceutical companies (please visit here(New Window) for the Global 100 ranking).
The Global 100 evaluates the sustainability of more than 6,000 of the world's major corporations based on various corporate initiatives in areas such as ESG (environment, society and governance). Since 2005, those companies ranking among the top 100 in the world have been announced each year. The Global 100 is based on up to 25 key performance indicators covering ESG initiatives, with the evaluations carried out based on data publicly disclosed in financial filings, integrated reports, or through other such channels. Eisai was highly evaluated, particularly in indicators for enhancing employee value such as safe work environment, sick leave support system and employee retention rate.
Eisai's corporate concept is to give first thought to patients and the people in the daily living domain, and increase the benefits that health care provides to them as well as meet their diversified healthcare needs worldwide. Based on this human health care (hhc) corporate concept, Eisai is striving to sustainably enhance corporate value by strengthening its ESG initiatives and increasing non-financial value.
Media Inquiries:
Public Relations Department,
Eisai Co., Ltd.
+81-(0)3-3817-5120
Source: Eisai
Sectors: BioTech
Copyright ©2023 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
Toyota Announces Changes to Organizational Structure and Senior Professionals/Senior Management
May 31, 2023 22:44 JST
MHI: Continuation of Maintenance of Manila MRT-3 in the Philippines
May 31, 2023 21:58 JST
Mitsubishi Motors to Unveil an All-New Compact SUV in Indonesia in August - Equipped with a New Automotive Sound System as a Collaboration with Yamaha
May 31, 2023 19:11 JST
Tokyo Kiraboshi FG and MC Sign Business Alliance Agreement
May 31, 2023 12:20 JST
Nissan, Mitsubishi Motors, and NMKV mark production of 50,000th fully electric minivehicle
May 31, 2023 11:56 JST
AWS Direct Connect location established at the NEC Inzai Data Center to create a hybrid cloud environment
May 31, 2023 11:04 JST
Daimler Truck, Mitsubishi Fuso, Hino and Toyota Motor Corporation conclude an MoU on accelerating development of Advanced Technologies and merging Mitsubishi Fuso and Hino Motors
May 30, 2023 20:15 JST
Mazda Production and Sales Results for April 2023
May 30, 2023 20:02 JST
Presto Partners VSING in Loyalty Points Collaboration
May 30, 2023 20:00 JST
Honda: Production, Sales and Export Results for April, 2023
May 30, 2023 16:06 JST
Toyota: Sales, Production, and Export Results for April 2023
May 30, 2023 15:12 JST
TANAKA Precious Metals to Exhibit at "Medtec China 2023" Medical Device Design and Manufacturing Exhibition, to be Held in Suzhou, China
May 30, 2023 15:00 JST
TANAKA Precious Metals to Exhibit at "Medtec China 2023" Medical Device Design and Manufacturing Exhibition, to be Held in Suzhou, China
May 30, 2023 15:00 JST
Shanghai MHI Engine Celebrates 10th Anniversary
May 30, 2023 14:32 JST
Fujitsu and Microsoft Announce Global Partnership to Enable "Sustainability Transformation"
May 30, 2023 14:03 JST
Olympus Names Wenlei Yang the Newly Established Chief Diversity, Equity and Inclusion Officer
May 29, 2023 15:00 JST
Olympus Names Wenlei Yang the Newly Established Chief Diversity, Equity and Inclusion Officer
May 29, 2023 15:00 JST
Toyota: Development and Verification of Stationary Storage Battery System Using Electric Vehicle Storage Batteries
May 29, 2023 13:31 JST
Mitsubishi Electric and Mitsubishi Heavy Industries Definitively Agree to Integrate Their Power-generator Systems Businesses
May 29, 2023 11:24 JST
Liquid Hydrogen-Powered Corolla to Participate in the Super Taikyu Fuji 24 Hours Race
May 29, 2023 09:08 JST
More Latest Release >>
Related Release
LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Demonstrates Long-Term, Durable Survival Benefit Versus Sunitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma
5/26/2023 2:15:00 PM JST
Eisai's Initiatives for Developing New Medicines for Neglected Tropical Diseases and Malaria
5/25/2023 9:02:00 PM JST
Eisai Delivers New Data and Highlights Continued Progress of Oncology Portfolio and Pipeline at ASCO 2023
5/24/2023 6:03:00 PM JST
Eisai Submits Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer's Disease in Great Britain
5/20/2023 10:20:00 AM JST
Health Canada Accepts New Drug Submission for Lecanemab as Treatment for Early Alzheimer's Disease
5/16/2023 9:27:00 AM JST
Eisai Enters Into Joint Development Agreement with Blissbio for Antibody Drug Conjugate BB-1701 with Option Rights for Strategic Collaboration
5/8/2023 11:15:00 AM JST
Eisai Completes a Major Renovation of Tsukuba Research Laboratories
4/6/2023 6:32:00 PM JST
Eisai Publishes Long-Term Health Outcomes Using Simulation Model of Lecanemab Using Phase 3 Clarity Ad Data in Peer-Reviewed Neurology and Therapy Journal
4/4/2023 1:23:00 PM JST
Eisai Enters Into Agreement With National Cancer Center to Collaborate on Investigator-Initiated Clinical Research for Anticancer Agent Tazemetostat Based on "Patient-Proposed Healthcare Services" System
4/3/2023 1:06:00 PM JST
Eisai Presented New Analyses of Aria and QOL on Lecanemab in Clarity AD at the AD/PD 2023 Annual Meeting
3/31/2023 4:51:00 PM JST
More Press release >>